132 related articles for article (PubMed ID: 11650830)
1. Reasonableness versus rationality in the construction and justification of science policy decisions: the case of the Cambridge Experimentation Review Board.
Waddell C
Sci Technol Human Values; 1989; 14(1):7-25. PubMed ID: 11650830
[No Abstract] [Full Text] [Related]
2. The regulation of recombinant DNA research: the alternative of local control.
Rosenblatt DP
Boston Coll Environ Aff Law Rev; 1982; 10(1):37-78. PubMed ID: 11649694
[No Abstract] [Full Text] [Related]
3. Recombinant DNA: legal responses to a new biohazard.
Balmer TA
Environ Law; 1977; 7(2):293-313. PubMed ID: 11661448
[No Abstract] [Full Text] [Related]
4. Molecular biology or molecular politics? The production of scientific consensus on the hazards of recombinant DNA technology.
Wright S
Soc Stud Sci; 1986 Nov; 16(4):593-620. PubMed ID: 11650809
[No Abstract] [Full Text] [Related]
5. Science vs. the public.
Norman C
Nature; 1976 Jul; 262(5565):163-5. PubMed ID: 11643318
[No Abstract] [Full Text] [Related]
6. Recombinant DNA research: a debate on the benefits and risks.
Davis BD; Chargaff E; Krimsky S
Chem Eng News; 1977 May; 55(22):26-42. PubMed ID: 11661587
[No Abstract] [Full Text] [Related]
7. Recombinant DNA and technology assessment.
Georgetown Law J; 1977; 11(4):785-878. PubMed ID: 11664859
[No Abstract] [Full Text] [Related]
8. The politics of deoxyribonucleic acid.
Budrys A
New Repub; 1977 Apr; 176(16):18-21. PubMed ID: 11662375
[No Abstract] [Full Text] [Related]
9. Institutional biosafety committees and the inadequacies of risk regulation.
Bereano PL
Sci Technol Human Values; 1984; 9(4):16-34. PubMed ID: 11649608
[No Abstract] [Full Text] [Related]
10. The Cambridge model: how public oversight of biotech is good for everyone--even business.
Lipson S
Genewatch; 2003; 16(5):7-10. PubMed ID: 15025120
[No Abstract] [Full Text] [Related]
11. A science for the people.
King J
New Sci; 1977 Jun; 74(1056):634-6. PubMed ID: 11663772
[No Abstract] [Full Text] [Related]
12. Doubts over genetic engineering controls.
Wright S
New Sci; 1976 Dec; 72(1029):520-1. PubMed ID: 11663697
[No Abstract] [Full Text] [Related]
13. Recombinant DNA research; actions under guidelines; notice.
U.S. National Institutes of Health
Fed Regist; 1984 Apr; 49(81):17844-8. PubMed ID: 11655581
[No Abstract] [Full Text] [Related]
14. Guidelines for research involving recombinant DNA molecules.
U.S. National Institutes of Health
Fed Regist; 1984 Nov; 49(227):46266-91. PubMed ID: 11655642
[No Abstract] [Full Text] [Related]
15. Science vs. politics in Boston.
Suzuki DT
Sci Forum; 1977 Jun; 10(3):16. PubMed ID: 11650573
[No Abstract] [Full Text] [Related]
16. The social warp of science: writing the history of genetic engineering policy.
Wright S
Sci Technol Human Values; 1993; 18(1):79-101. PubMed ID: 11652076
[No Abstract] [Full Text] [Related]
17. Molecular politics in a global economy.
Wright S
Politics Life Sci; 1996 Sep; 15(2):249-63. PubMed ID: 11654797
[No Abstract] [Full Text] [Related]
18. Recombinant DNA: a case study in regulation of scientific research.
Chalfant JC; Hartmann ME; Blakeboro A
Ecol Law Q; 1979; 8(1):55-129. PubMed ID: 11665069
[No Abstract] [Full Text] [Related]
19. Genetic manipulation: recommendations drafted.
Norman C
Nature; 1975 Dec; 258(5536):561-4. PubMed ID: 11643295
[No Abstract] [Full Text] [Related]
20. Recombinant DNA research: proposed actions under the guidelines; notice.
U.S. National Institutes of Health
Fed Regist; 1997 Feb; 62(31):7108-23. PubMed ID: 11654870
[No Abstract] [Full Text] [Related]
[Next] [New Search]
